Corona 19 Vaccine Side Effects: Dizzy & More
- New studies have shown that people with long-term side effects from COVID-19 vaccines may cause dormant virus revitalization and additional problems in which coronavirus proteins in the blood...
- The COVID-19 vaccines prevented millions of deaths by strong preventive effects.
- According to a study led by Professor Akiko Iwasaki (immunology) at Yale University Medical School, some of the PVS holders change the proportion of immune cells, the revitalization...
New Studies Reveal Long-Term Side Effects of COVID-19 Vaccines
Table of Contents
- New Studies Reveal Long-Term Side Effects of COVID-19 Vaccines
- New Studies reveal Long-Term Side Effects of COVID-19 Vaccines
- Frequent Queries About COVID-19 Vaccine Long-Term Effects
- 1. What are the long-term side effects of COVID-19 vaccines?
- 2. How do COVID-19 vaccines impact the immune system long-term?
- 3. Are the long-term side effects common?
- 4. Do the benefits of COVID-19 vaccines outweigh potential long-term side effects?
- 5. What is being done to further investigate and address long-term side effects?
- 6.How can individuals support those experiencing long-term side effects?
- 7. What are potential treatments for long-term vaccine side effects?
- Frequent Queries About COVID-19 Vaccine Long-Term Effects
New studies have shown that people with long-term side effects from COVID-19 vaccines may cause dormant virus revitalization and additional problems in which coronavirus proteins in the blood may occur. The New York Times reported on the 19th (local time) based on the research published in the medical pre-print site Medrxiv by researchers at Yale University.
The COVID-19 vaccines prevented millions of deaths by strong preventive effects. However, some people have various side effects such as fatigue, exercise intolerance, brain fog, tinnitus, and dizziness. It is also called ‘post-vaccination syndrome · PVS’.
According to a study led by Professor Akiko Iwasaki (immunology) at Yale University Medical School, some of the PVS holders change the proportion of immune cells, the revitalization of the Epstein-Barr virus (EBV) in the dormant state of the body, the continuity of the coronavirus protein in the blood, and additional biological changes such as the back have occurred. Professor Iwasaki said, “It’s still a study.” “It is not the first study of what’s going on in their bodies, but it is the first study.”
The researchers collected blood samples from December 2022 to November 2023 from 42 PVS and 22 healthy people without vaccination. PVS holders have been investigated in different proportions of some immune cells compared to the control group. The researchers did not associate these differences with individual symptoms.
The symptoms reported by PVS holders overlap with long-term COVID-19 (Long COVID). The researchers also analyzed the blood of 134 long COVID patients and 134 healthy controls.
Similar to long COVID patients, PVS holders have been revitalized by EBVs in a long-term dormant state. EBVs belonging to the herpes group have about 90% of humans, but they are usually dormant.
Some of the long COVID cases are believed to occur because the spike protein of the coronavirus persists and the inflammation of the body is increased. The researchers found that the plasma levels of the coronavirus spike protein of those with PVS between 26 and 709 days after vaccination were much higher than everyone else. Professor Iwasaki said that because they have been vaccinated for a long time, the mRNA vaccine is unlikely to be a source of protein.
Scholars who reviewed the papers were a small study, but Iwasaki researchers said that further research on PVS seems to be needed in that it has been reputed to strict research. John Warri, director of the Pennsylvania University immunology research institute, said, “During the fan-decicator, scientists were trapped in the idea that they should not talk about this if they did not give a clear answer, but it was revealed that it was a mistake.” To illuminate light and continue to make efforts to understand what the identity is It’s important.”
This paper can be found at the following link (https://www.medrxiv.org/content/10.110/2025.02.18.253232379v1).
Implications for the U.S. Public
As the U.S. continues to grapple with the long-term effects of COVID-19, these findings shed light on the potential risks associated with vaccination side effects. The study highlights the importance of monitoring and addressing the symptoms of PVS, which can significantly impact the quality of life for affected individuals.
For instance, a recent case study from a hospital in New York City revealed that a patient with PVS experienced severe fatigue and brain fog, which affected their ability to work and perform daily activities. This underscores the need for further research and support for those experiencing long-term side effects from COVID-19 vaccines.
Potential Counterarguments
Critics may argue that the study’s small sample size limits its generalizability. However, the researchers emphasize the need for further investigation to better understand the mechanisms behind PVS and its potential long-term effects. As John Warri, director of the Pennsylvania University immunology research institute, stated, “It’s important to illuminate light and continue to make efforts to understand what the identity is.”
Furthermore, while the study highlights the potential risks, it is crucial to remember that the benefits of vaccination far outweigh the risks for the majority of the population. The COVID-19 vaccines have been instrumental in preventing severe illness and death, and ongoing research aims to address any potential side effects.
Recent Developments
Recent developments in the field of immunology have led to new insights into the mechanisms behind PVS. Researchers are now exploring the role of the immune system in the reactivation of dormant viruses and the persistence of coronavirus proteins in the blood. This research could pave the way for new treatments and interventions to address the long-term side effects of COVID-19 vaccines.
For example, a new study published in the Journal of Immunology suggests that targeted immune therapies could help mitigate the symptoms of PVS by modulating the immune response. This approach could provide relief for individuals experiencing long-term side effects and improve their overall quality of life.
Practical Applications
Understanding the mechanisms behind PVS is crucial for developing practical applications to support affected individuals. Healthcare providers can use this knowledge to better diagnose and manage the symptoms of PVS, ensuring that patients receive the care they need. Additionally, ongoing research and public awareness campaigns can help address the stigma surrounding long-term side effects and encourage affected individuals to seek help.
For instance, a support group in California has been established to provide resources and community for individuals experiencing PVS. The group offers educational materials, support meetings, and access to healthcare providers specializing in long-term side effects. This initiative highlights the importance of community support and education in addressing the challenges posed by PVS.
New Studies reveal Long-Term Side Effects of COVID-19 Vaccines
Frequent Queries About COVID-19 Vaccine Long-Term Effects
1. What are the long-term side effects of COVID-19 vaccines?
New research indicates that some individuals may experience long-term side effects following COVID-19 vaccination, such as fatigue, exercise intolerance, brain fog, tinnitus, and dizziness—referred to as “post-vaccination syndrome” (PVS). Studies suggest these effects may also involve the reactivation of the Epstein-Barr virus (EBV) and elevated levels of coronavirus spike proteins in the blood [1].
2. How do COVID-19 vaccines impact the immune system long-term?
Research led by Professor Akiko Iwasaki at Yale University has found that COVID-19 vaccines might alter the proportion of certain immune cells and reactivate dormant viruses like EBV. This could explain symptoms related to both PVS and long COVID, though these findings require further research to confirm [1].
3. Are the long-term side effects common?
While some individuals report experiencing long-term symptoms, they are not universally experienced. The occurrence of long-term side effects like PVS appears to overlap with long-term COVID-19 symptoms, yet not all vaccinated individuals will experience these effects. Research is ongoing to understand the prevalence and specific risk factors [1].
4. Do the benefits of COVID-19 vaccines outweigh potential long-term side effects?
Despite the potential for long-term side effects, the overall benefits of COVID-19 vaccination are substantial. Vaccines have prevented millions of deaths by providing strong preventive effects against severe illness and complications from COVID-19. Researchers and experts emphasize the importance of continuing vaccination while investigating and addressing any adverse effects [2].
5. What is being done to further investigate and address long-term side effects?
Research into the long-term side effects of COVID-19 vaccines is ongoing. Efforts include studying the immune system’s role in these effects and exploring targeted therapies that might alleviate symptoms related to PVS. Public awareness and support groups have been established to help those experiencing long-term effects. Further investigation is needed to deepen understanding and develop effective interventions [1].
6.How can individuals support those experiencing long-term side effects?
Supporting individuals experiencing long-term side effects can involve:
– Encouraging them to seek medical advice and support.
– Providing access to community resources and support groups.
– Promoting awareness to reduce stigma around long-term side effects.
– Keeping informed about ongoing research and advancements in treatments.
7. What are potential treatments for long-term vaccine side effects?
New studies suggest that targeted immune therapies might help mitigate symptoms by modulating the immune response. ongoing research aims to develop such therapies and improve the quality of life for individuals affected by long-term side effects [1].